(Date:9/5/2008)...s the Latest Developments in Molecular,Testing and... /PRNewswire-USNewswire/ -- The practice of,pathol...g and the promise,of personalized medicine will ch...and other imaging technologies will change the way...ogists is taking a leadership role in,making sure ...
(Date:9/5/2008)...RNewswire-USNewswire/ -- The Health Resources,and ... million in grants to,increase and improve medical... grants continue President Bush,s historic expansi...w reach more economically,vulnerable and geographi...dministrator Elizabeth M. Duke said. "In 2007, mor...
(Date:9/5/2008)...tical ,anti-cloak, could bring objects out of hidi...-- Just in case someone develops a cloak of invisi... how to uncloak the objects it hides. , Accordi...in materials underneath an invisibility cloak woul...esearchers at Shanghai Jiao Tong University in Chi...
(Date:9/5/2008)...ain to commit to develop a National AIDS,Strategy ...p. 5 /PRNewswire-USNewswire/ -- The,Republican Nat...ion of the,domestic AIDS epidemic in the United St...erseas. Neither Presidential nominee Sen. John McC... mentioned AIDS in their remarks,to Convention del...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 3(Date:9/5/2008)... Sept. 5 /PRNewswire-USNewswire/ -- Cancer patient...nown as chemobrain. Now in,animal studies at West ...hat injections of N-acetyl cysteine (NAC), an anti...ancer chemotherapy drugs sometimes induce., In th...er issue of the,journal Metabolic Brain Disease, r...
(Date:9/4/2008)...ia, Sept. 4 /- Cytopia Limited (ASX:,...nt for its Phase Ib/II,study of CYT997, the compan... patients with an aggressive form of brain cancer ...clinical trial is the first Phase II efficacy stud...the company and the second in its,suite of Phase I...
(Date:9/4/2008)...for Obstetrician-Gynecologists States UFE Meets Le...lly Invasive Interventional,Radiology Treatment Is...roids, FAIRFAX, Va., Sept. 4 /PRNewswire-USNewswi...national organization of nearly 4,500 doctors,sci...to improving health,care through minimally invasiv...
(Date:9/4/2008)...trates potent antiviral activity and favorable saf...RIDGE, Mass., Sept. 4 /- Id...pharmaceutical company engaged,in the discovery an...viral,and other infectious diseases, today announc...y evaluating IDX899, a non-nucleoside reverse,tran...
Breaking Medicine Technology:Study Suggests a Possible Way to Offset Chemobrain Memory Loss 2Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 2Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4New Study Shows Arthritis Significantly Limits Millions of Americans Ability to Work 3484 1New Study Shows Arthritis Significantly Limits Millions of Americans Ability to Work 3484 2New Study Shows Arthritis Significantly Limits Millions of Americans Ability to Work 3484 3Analysis of breast and colon cancer genes finds many areas of differences between tumors 763 1EPA 3A Nine Indiana Counties Now Meet the Health Standard for Smog 3482 1U S Secretary of Labor launches Drug Free Work Week 3479 1U S Secretary of Labor launches Drug Free Work Week 3479 2...of Multi-Center Trial in 4 Weeks Reinforces,Benefi...loma-, NORTH HOLLYWOOD, Calif., May 15, 2007 /PRNe...MF) - supporting research and,providing education,...es, researchers and physicians - today said that f...eloma trial using,REVLIMID(R) has demonstrated pos...
... ISIS 301012 produced at least 45% additional,redu...aximally-tolerated lipid-lowering therapies, CARLS...- Isis,Pharmaceuticals, Inc. announced updated res...IS 301012 in patients with homozygous,familial hyp... were,presented in March at the of Cardiology Annu...
Other Medicine Technology:The International Myeloma Foundation Reports Positive Shift In,Treatment Paradigm For Patients 2The International Myeloma Foundation Reports Positive Shift In,Treatment Paradigm For Patients 3Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 2Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 3Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 4Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 5...oft, foam-lined FoamWrap ThumWrap Splints offer su...lints. Ideal to relieve mild pain or strain due to... Choose either the rigid or the flexible stay to p...and breathable, the ThumWrap Splint is comfortable...
...his lightweight orthosis is designed to comfortabl...ding the hand in a neutral position. It is fabrica...oplastic whose unique characteristics offer durabl...thosis provides rigid cast-like immobilization of ...
...he CTi Wrist Flex is a custom wrist orthotic desig...t specific to the patient's maximum range-of-motio...ist sprains with TFCC tear-triangular fibrocartila...Scaphoid nonunion , Partial tendon rupture , O...
Singe-pull lace design provides easy-on application to provide support and immobilization of the wrist while preserving finger mobility
Medicine Products: